Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,168 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

NCT00002336

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Univ of Arizona / Health Science Ctr Tucson, Arizona, United States
  • California Med Research Group Fresno, California, United States
  • HIV Research Group San Diego, California, United States
  • Saint Francis Mem Hosp San Francisco, California, United States
View all 22 locations
View Trial Details
Completed

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS

NCT00002331

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Kaiser Permanente Med Ctr Los Angeles, California, United States
  • UCD Med Ctr Sacramento, California, United States
  • Kaiser Permanente Med Ctr San Francisco, California, United States
  • Santa Clara Valley Med Ctr San Jose, California, United States
View all 18 locations
View Trial Details
Completed

Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients

NCT00876733

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site 14 Aachen, Germany
  • Boehringer Ingelheim Investigational Site 12 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 13 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 15 Berlin, Germany
View all 66 locations
View Trial Details
Completed

Male Engagement in PMTCT Services

NCT01903889

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • Bukinda Health Center Kabale, Uganda
  • Kamkira Health Center Kabale, Uganda
  • Kamwezi Health Center Kabale, Uganda
  • Maziba Health Center Kabale, Uganda
View Trial Details
Completed

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

NCT01221298

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +11 more
Locations
  • Site Reference ID/Investigator# 41128 Los Angeles, California, United States
  • Site Reference ID/Investigator# 42262 Chicago, Illinois, United States
  • Site Reference ID/Investigator# 41127 San Antonio, Texas, United States
  • Site Reference ID/Investigator# 43182 Seattle, Washington, United States
View Trial Details
Completed

A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072

NCT01074008

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +11 more
Locations
  • Site Reference ID/Investigator# 23392 Phoenix, Arizona, United States
  • Site Reference ID/Investigator# 23370 Anaheim, California, United States
  • Site Reference ID/Investigator# 23387 La Jolla, California, United States
  • Site Reference ID/Investigator# 23388 Los Angeles, California, United States
View all 26 locations
View Trial Details

Related conditions